Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-1/Smad Pathway and Epithelial to Mesenchymal Transition

被引:16
|
作者
Meng, Lihong [1 ]
Zhang, Xiaomei [2 ]
Wang, Hong [3 ,4 ]
Dong, Huan [1 ]
Gu, Xiaofeng [1 ]
Yu, Xiaolin [1 ]
Liu, Yushan [1 ]
机构
[1] Beijing Univ Chinese Med, 11 North 3rd Ring Rd, Beijing 100029, Peoples R China
[2] Beijing Univ Chinese Med, Dongfang Hosp, Dept Resp Med, 6 1st Dist Fangxingyuan, Beijing 100078, Peoples R China
[3] Shunyi Hosp, Beijing Chinese Med Hosp, 5 Zhanqian East St, Beijing 101300, Peoples R China
[4] Capital Med Univ, Beijing Chinese Med Hosp, Art Museum, 23 Houjie St, Beijing 100010, Peoples R China
关键词
MYOFIBROBLAST; ACTIVATION; MECHANISMS; RECEPTOR;
D O I
10.1155/2019/2710509
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-1/Smad signal pathway and epithelial to mesenchymal transition (EMT). Methods. 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson's trichrome to observe histopathological changes. Protein levels of TGF-1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-1, TRI, TRII, Smad3, Smad7, -SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. Results. TGF-1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I were significantly increased (p <0.01), while Smad7 and E-cadherin levels were significantly decreased in BLM group (p <0.01). YYYQ-M and YYYQ-H group had downregulated the TGF-1, CTGF, hydroxyproline contents, and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p <0.01 or p <0.05). The result from the present study, which was also supported by histological evidence, suggested that YYYQ-M group and YYYQ-H group exhibited better treatment effect on Bleomycin-induced pulmonary fibrotic rats when compared to that of BLM + Pred group (p <0.01). Meanwhile, the effect of YYYQ, in three different dosages, on the level of interleukin 18 was not significant. Conclusion. These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Oleanolic Acid Acetate Alleviates Bleomycin-Induced Pulmonary Fibrosis Via Inhibiting Epithelial-Mesenchymal Transition
    Jung, J.
    Jeong, E.
    Hwang, K.
    Park, C.
    Lim, H.
    Kim, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] NecroX-5 ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3-mediated epithelial-mesenchymal transition
    Li Min
    Zhang Shu-Li
    Yuan Feng
    Hu Han
    Li Shao-Jun
    Tong Sheng-Xiong
    Tian Jia-Yu
    Fang Xiang-Zhi
    Feng Dan
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [23] Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway
    Gu, Songtao
    Liang, Jingjing
    Zhang, Jianwei
    Liu, Zhichao
    Miao, Yang
    Wei, Yuli
    Li, Shimeng
    Gu, Jinying
    Cui, Yunyao
    Xiao, Ting
    Li, Xiaohe
    Yang, Cheng
    MOLECULES, 2023, 28 (05):
  • [24] Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway
    Li, Xiaohe
    Ma, Ling
    Huang, Kai
    Wei, Yuli
    Long, Shida
    Liu, Qinyi
    Zhang, Deqiang
    Wu, Shuyang
    Wang, Wenrui
    Yang, Guang
    Zhou, Honggang
    Yang, Cheng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 16
  • [25] Silencing FHL2 inhibits bleomycin-induced pulmonary fibrosis through the TGF-β1/Smad signaling pathway
    Shi, Mengkun
    Cui, Huixia
    Shi, Jialun
    Mei, Yunqing
    EXPERIMENTAL CELL RESEARCH, 2023, 423 (02)
  • [26] 2-aminopurine suppresses the TGF-β1-induced epithelial–mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosis
    Dong Weng
    Jian-xia Chen
    Hao-hao Li
    Feng Liu
    Li-dan Zhou
    Hai-peng Liu
    Rui-juan Zheng
    Yan Jiang
    Zhong-hua Liu
    Baoxue Ge
    Cell Death Discovery, 4
  • [27] Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis
    Qian, Weibin
    Cai, Xinrui
    Qian, Qiuhai
    Zhang, Wei
    Wang, Dongli
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (09) : 4354 - 4365
  • [28] Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β/Smad3 Pathway
    Ding, Lu
    Li, Yaxin
    Yang, Yingying
    Song, Siyu
    Qi, Hongyu
    Wang, Jing
    Wang, Ziyuan
    Zhao, Jiachao
    Zhang, Wei
    Zhao, Linhua
    Zhao, Daqing
    Li, Xiangyan
    Wang, Zeyu
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [29] Geniposide ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β/Smad and p38MAPK signaling pathways
    Yin, Jian-Bin
    Wang, Ying-Xia
    Fan, Su-Su
    Shang, Wen-Bin
    Zhu, Yu-Shan
    Peng, Xue-Rong
    Zou, Cheng
    Zhang, Xuan
    PLOS ONE, 2024, 19 (09):
  • [30] Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1/Smad Pathway
    Yao, Huan
    Wei, Shujun
    Xiang, Yongjing
    Wu, Ziqiang
    Liu, Weiwei
    Wang, Baojia
    Li, Xueping
    Xu, Huan
    Zhao, Juan
    Gao, Yongxiang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019